Akeso Announces FDA Approval for Penpulimab-kcqx in Two BLA Indications for Comprehensive Treatment of Advanced Nasopharyngeal Carcinoma HONG KONG, April 25, 2025 /PRNewswire/ — Akeso, Inc. (9926.HK) ("Akeso" or… CISION PRNewswireApril 25, 2025
Press ReleaseA Visionary Breakthrough: VISTA Eye Specialist and EssilorLuxottica Join Forces to Combat Childhood Myopia in Malaysia PETALING JAYA, Malaysia, April 25, 2025 /PRNewswire/ — In a landmark move… CISION PRNewswireApril 25, 2025
Press ReleaseGlobal Media Witnesses Chery Super Hybrid (CSH)'s Breakthrough as 'Endless Horizon Worry-Free Voyage' Endurance Challenge Completes First Stage SHANGHAI, April 25, 2025 /PRNewswire/ — On April 23, coinciding with the… CISION PRNewswireApril 25, 2025
Press ReleaseZERO BREEZE Partners with NASCAR Driver Patrick Emerling to Bring Cooling Innovation to the Track LINCOLN, Ala., April 25, 2025 /PRNewswire/ — ZERO BREEZE, a leader in portable… CISION PRNewswireApril 25, 2025
Theo Raises $20M to Democratize Access to Institutional-Grade Trading Infrastructure Founded by ex-Optiver and IMC quants, the platform is backed by angels… CISION PRNewswireApril 24, 2025
VivaVision Announces Positive Topline Results from Phase 2 Trial of VVN461 for Non-Infectious Anterior Uveitis VVN461, a dual JAK1/TYK2 inhibitor as a non-steroidal anti-inflammatory agent, has met… CISION PRNewswireApril 24, 2025
Press ReleaseMedit and Graphy Announce Strategic Partnership to Advance Digital Orthodontics SEOUL, South Korea, April 25, 2025 /PRNewswire/ — Medit, a global leader… CISION PRNewswireApril 24, 2025
Press ReleaseViewSonic Earns EcoVadis Silver Rating for Sustainability Excellence Ranked in the Top 8% of Rated Companies Worldwide for ESG Performance… CISION PRNewswireApril 24, 2025
